Insider buying last 90 days
No open-market insider purchases were filed for ARDT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ARDT insider filing, plotted on the chart in Gekko.Open ARDT in Gekko
NYSE: ARDT
Ardent Health (ARDT) Stock Analysis & Forecast
Oct 12 close
$11.53+0.23 (+2.0%)
Gekko Brief
AI summaryOct 12 closeThis week's attention centers on analyst activity around Ardent Health. RBC Capital's Ben Hendrix reaffirmed a Buy rating with a $13.00 price target following his October 7 analysis, while BMO Capital initiated coverage with a Hold rating and Truist Financial issued a Buy rating. Separately, ARDT drew a comparison against OPKO Health across profitability, valuation, analyst recommendations and institutional ownership.
ARDT closed at $11.53, up 2%, sitting above both its 50-day average of $10.87 and its 200-day average of $9.77, with the 50-day above the 200-day. The stock's one-month return stands at 5%, its three-month return at 17.7%, and its six-month return at 24.4%, though the one-year return remains at -19.6%. The GekkoIndex reads 46.1, placing it in the Neutral zone, down 14.4 over the past five readings. Gekko Fair Value is set at $18.92, putting the current price 39.1% below that level.
Looking ahead, Ardent Health's next earnings report is scheduled for 11 November 2026, 29 days out, which falls outside a typical 20-trading-day holding window. The prior quarter saw an EPS of $0.32 against an estimate of $0.35, with a reaction of 0.3%, and the company has beaten estimates in 6 of its last 8 quarters. Consensus among 9 firms shows 5 Buy, 3 Hold, and 1 Sell ratings, with a consensus target of $12.67. No insider, Congress, or unusual options activity appears in the current windows.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Ardent Health price vs fair value
Close $11.53200-day averageGekko Fair Value $18.92
Ardent Health quick facts
- Market cap
- $1.65B
- P/E ratio
- 20.2
- Forward P/E
- 9.5
- EPS, TTM
- $0.54
- Revenue, TTM
- $6.41B
- Profit margin
- 1.2%
- Dividend yield
- —
- Beta
- 0.72
- Volume
- 563,577 avg 451,366
- 1-year return
- −19.6%
- Typical daily move
- ±3.5%
- Typical 20-day move
- ±7.3%
- 50-day average
- $10.87
- 200-day average
- $9.77
- Next earnings
- Nov 11
- Shares outstanding
- 141.0M
Ardent Health swing-trade checklist
Ardent Health scores 3 supportive, 1 mixed and 0 headwinds across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $11.53 is above the 50-day ($10.87) and 200-day ($9.77) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
46.1, Neutral
Reading 46.1 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
39.1% below
Price is 39.1% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Nov 11, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Ardent Health stock chart and price history
Ardent Health closed at $11.53 on Oct 12, 2026, −19.6% over the past year, inside a 52-week range of $7.71 to $15.48.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +5.0%
- 3 months
- +17.7%
- 6 months
- +24.4%
- 1 year
- −19.6%
The full ARDT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ARDT in Gekko
Follow Ardent Health through every session
Put ARDT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ARDT in GekkoFree for 7 days. No credit card required.
About Ardent Health
Ardent Health runs a collection of hospitals and clinics across the United States, delivering patient care that spans both inpatient stays and outpatient visits. Its medical offerings cover a broad range of fields, among them internal medicine, surgery, heart care, cancer treatment, orthopedics, women's health, neurology, urology and emergency medicine. The company is widely recognized for combining acute hospital care with a wider network of community-based health facilities.
Beyond its hospital campuses, Ardent Health maintains a system of outpatient sites that includes primary and specialty clinics, surgical centers, urgent care locations, standalone emergency rooms, and imaging facilities, along with telehealth options for patients seeking remote consultations. Its hospital holdings extend to rehabilitation and surgical facilities as well as general acute care centers, reflecting a mix of specialized and broad-based medical services. The company operates as a subsidiary of EGI-AM Investments, L.L.C.
Headquartered in Brentwood, Tennessee, Ardent Health traces its founding back to 2001 and previously operated under the name Ardent Health Partners before adopting its current title in June 2025. Its shares are listed on the NYSE under the ticker ARDT.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Website
- ardenthealth.com
Ardent Health GekkoIndex: the smart money zone
Ardent Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46.1, in the Neutral zone, down 14.4 points over five sessions.
46.1Neutral
Down 14.4 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 23 | +1.1% | +9.1% | ||
| Accumulation | 222 | +0.8% | +2.1% | ||
| Neutral (current zone) | 289 | −0.8% | −3.0% | ||
| Distribution | 21 | −1.4% | −8.6% | ||
| Selling | 0 | Not available | |||
Average ARDT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ARDT price, zone by zone.Track ARDT in Gekko
Is Ardent Health stock overvalued? Gekko Fair Value
Ardent Health trades 39.1% below Gekko Fair Value of $18.92, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Ardent Health shares are worth, recalculated every trading day.
$18.92
Gekko Fair Value, Oct 9, 2026
39.1% Undervalued
At the end of Aug 2026 the price was 8.1% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open ARDT in Gekko
Ardent Health insider and Congress trading
No open-market insider purchases were filed for Ardent Health, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ARDT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ARDT, plotted on the chart in Gekko.Open ARDT in Gekko
Buybacks
Ardent Health has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $13.03M
- As a share of market cap
- 0.79%
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold ARDT.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Ardent Health earnings: next date and track record
Ardent Health reports on Nov 11, 2026 (30 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 11, 2026
30 days away
- EPS estimate
- $0.24
- Revenue estimate
- $1.60B
6 of 8reports beat the EPS estimate
±9.3%average move across the report
5 of 7reports followed by a gain
Share-price move across each report
Last earnings call, Mar 4, 2026 AI summary
- What they said
- Ardent Health reported record 2025 full-year revenue of $6.3 billion (up 6%), adjusted EBITDA growth of 9% with 20bps margin expansion, and operating cash flow of $471 million (up 49% YoY). Q4 showed stability in professional fees and payer denial pressures. The IMPACT program drove SWB expenses down 0.4% YoY in Q4, contract labor fell 26% to $17M, and balance sheet strengthened with cash exceeding $700M and leverage reduced to 2.5x.
- Guidance
- Management raised IMPACT program annualized savings target from $40M to approximately $55M, expecting run-rate entering 2026. Operating performance traction is expected to further ramp throughout 2026.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 4, 2026 | $0.32 est $0.35 | $1.61B est $1.63B | +0.3% |
| Nov 12, 2025 | $0.52 est $0.42 | $1.58B est $1.55B | −33.8% |
| Aug 5, 2025 | $0.52 est $0.30 | $1.65B est $1.63B | +9.6% |
| May 6, 2025 | $0.29 est $0.21 | $1.50B est $1.50B | +7.9% |
| Feb 26, 2025 | $0.81 est $0.50 | $1.61B est $1.50B | +4.9% |
| Nov 6, 2024 | $0.17 est $0.30 | $1.45B est $1.45B | −2.8% |
| Aug 14, 2024 | $0.34 est $0.30 | $1.47B est $1.46B | +6.0% |
| May 29, 2024 | $0.21 est $0.00 | — | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Ardent Health stock forecast and analyst price targets
Analysts’ average 12-month price target for Ardent Health is $12.67, +9.9% from the last close, from 9 firms rating the stock in the last 90 days.
$12.67consensus 12-month target, +9.9% from the last close
Now $11.53Avg $12.67
Low $10High $14
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 30 | Truist Financial | — | — |
| Sep 22 | BMO Capital | $11 | −4.6% |
| Sep 17 | Leerink Partners | — | — |
| Aug 10 | Goldman Sachs | $13 | +12.7% |
| Aug 10 | Bank of America Securities | $10 | −13.3% |
−3.0%average 20-day move after past Neutral readings
±3.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Ardent Health market cap and key statistics
Ardent Health’s market cap is $1.65B, with a P/E ratio of 20.2 and revenue of $6.41B over the last twelve months.
Valuation
- Market cap
- $1.65B
- P/E ratio
- 20.2
- Forward P/E
- 9.5
- EPS, TTM
- $0.54
- Gekko Fair Value
- $18.92
Trading
- Volume
- 563,577
- Avg volume, 20 days
- 451,366
- 52-week high
- $15.48
- 52-week low
- $7.71
- Shares outstanding
- 141.0M
Financials
- Revenue, TTM
- $6.41B
- Profit margin
- 1.2%
- Return on equity
- 10%
- Quarterly earnings growth, YoY
- −77.1%
Risk and income
- Beta
- 0.72
- Typical daily move
- ±3.5%
- Typical 20-day move
- ±7.3%
Ardent Health stock news this week
2 headlines about Ardent Health from the past week, newest first, each linking to the publisher.
- RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)The Globe and Mail, Oct 10
- Comparing Ardent Health (NYSE:ARDT) & OPKO Health (NASDAQ:OPK)Defense World, Oct 7
Ardent Health peers
Ardent Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 18.9% above |
| THCTenet Healthcare | Neutral | 6.7% below |
| UHSUniversal Health Services | Neutral | 21.4% below |
| PACSPACS | Neutral | 11.0% below |
| CHEChemed | Accumulation | 7.7% below |
| NHCNational HealthCare | Neutral | 30.5% above |
A peer links to its own page where one exists.
Ardent Health stock FAQ
What is Ardent Health’s market cap?
Ardent Health’s market cap is $1.65B at the Oct 12, 2026 close of $11.53, with 141.0M shares outstanding. The shares trade on a P/E ratio of 20.2.
What is the Ardent Health stock forecast?
The consensus analyst 12-month price target for Ardent Health is $12.67, +9.9% from the last close. Of the 9 firms that rated the stock in the last 90 days, 5 rate it a buy, 3 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Ardent Health stock overvalued or undervalued?
On Gekko’s estimate Ardent Health is undervalued: the Oct 12, 2026 close of $11.53 is 39.1% below Gekko Fair Value of $18.92. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Ardent Health report earnings next?
Ardent Health is expected to report on Nov 11, 2026 (30 days away). Analysts expect earnings of $0.24 per share on revenue of $1.60B. Ardent Health beat the earnings estimate in 6 of its last 8 reports, moving 9.3% on average across the report.
What is Ardent Health’s 52-week high and low?
Ardent Health’s 52-week high is $15.48 and its 52-week low is $7.71; it closed at $11.53 on Oct 12, 2026, −19.6% over the past year. Over the last five years the shares peaked at $20.72 on Oct 16, 2024.
Is Ardent Health stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 4 items with data read as supportive (trend, fair value and earnings risk), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Ardent Health the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.